1521. Heterogeneity of Recent Phase 3 cUTI Clinical Trials with New Antibiotics

BACKGROUND: For new antibiotics to treat Gram-negative infections, one regulatory pathway includes complicated urinary tract infections (cUTI) clinical trials. Although individual clinical trials comply with regulatory guidelines, they may differ substantially in design and execution. Six recent cUT...

Descripción completa

Detalles Bibliográficos
Autores principales: Bass, Almasa, Echols, Roger, Portsmouth, Simon, Howell, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253730/
http://dx.doi.org/10.1093/ofid/ofy210.1350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253730/
http://dx.doi.org/10.1093/ofid/ofy210.1350

Ejemplares similares